{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:14:33Z","timestamp":1768522473312,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.schres.2016.12.017","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T01:46:45Z","timestamp":1482889605000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Analysis of differential gene expression mediated by clozapine in human postmortem brains"],"prefix":"10.1016","volume":"185","author":[{"given":"Brian J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie E.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis L.","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie G.","family":"Nucifora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeewen Candace","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Pevsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell L.","family":"Margolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Frederick C.","family":"Nucifora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.schres.2016.12.017_bb0005","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/mp.2014.171","article-title":"Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder","volume":"20","author":"Arion","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2016.12.017_bb0010","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/jnr.20208","article-title":"Microarray analysis of postmortem temporal cortex from patients with schizophrenia","volume":"77","author":"Aston","year":"2004","journal-title":"J. Neurosci. Res."},{"issue":"5","key":"10.1016\/j.schres.2016.12.017_bb0015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.neuron.2014.07.028","article-title":"Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia","volume":"83","author":"Cabungcal","year":"2014","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.schres.2016.12.017_bb0020","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bdi.12039","article-title":"Gene expression alterations in bipolar disorder postmortem brains","volume":"15","author":"Chen","year":"2013","journal-title":"Bipolar Disord."},{"issue":"11","key":"10.1016\/j.schres.2016.12.017_bb0025","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0006-3223(01)01271-9","article-title":"Management of treatment resistance in schizophrenia","volume":"50","author":"Conley","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2016.12.017_bb0030","first-page":"691","article-title":"Clozapine: an atypical antipsychotic agent","volume":"8","author":"Ereshefsky","year":"1989","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.schres.2016.12.017_bb0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance","volume":"13","author":"Hasan","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2016.12.017_bb0040","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1176\/appi.ajp.162.12.2233","article-title":"Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies","volume":"162","author":"Honea","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.12.017_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/hmg\/ddi022","article-title":"Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis","volume":"14","author":"Iwamoto","year":"2005","journal-title":"Hum. Mol. Genet."},{"issue":"1\u20133","key":"10.1016\/j.schres.2016.12.017_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.schres.2010.07.001","article-title":"Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data","volume":"122","author":"Jia","year":"2010","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2016.12.017_bb0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2016.12.017_bb0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/mp.2015.141","article-title":"Molecular substrates of schizophrenia: homeostatic signaling to connectivity","volume":"21","author":"Landek-Salgado","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"30","key":"10.1016\/j.schres.2016.12.017_bb0065","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.1206118109","article-title":"Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110\u03b4 inhibition as a potential therapeutic strategy","volume":"109","author":"Law","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2016.12.017_bb0070","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.172.2.110","article-title":"Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies","volume":"172","author":"Lawrie","year":"1998","journal-title":"Br. J. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2016.12.017_bb0075","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1371\/journal.pgen.0030161","article-title":"Capturing heterogeneity in gene expression studies by surrogate variable analysis","volume":"3","author":"Leek","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.schres.2016.12.017_bb0080","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1038\/ncomms3739","article-title":"Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder","volume":"4","author":"Lencz","year":"2013","journal-title":"Nat. Commun."},{"issue":"9896","key":"10.1016\/j.schres.2016.12.017_bb0085","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2016.12.017_bb0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/7854_2010_53","article-title":"A selective review of volumetric and morphometric imaging in schizophrenia","volume":"4","author":"Levitt","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2016.12.017_bb0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2013\/748095","article-title":"Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia","volume":"35","author":"Mamdani","year":"2013","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.schres.2016.12.017_bb0100","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2016.12.017_bb0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","article-title":"Clozapine: balancing safety with superior antipsychotic efficacy","volume":"6","author":"Meltzer","year":"2012","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2016.12.017_bb0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values","volume":"25","author":"Meltzer","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2016.12.017_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2014.07.001","article-title":"New therapeutic approaches for treatment-resistant schizophrenia: a look to the future","volume":"58","author":"Miyamoto","year":"2014","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.schres.2016.12.017_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.schres.2016.12.017_bb0125","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cge.12485","article-title":"Novel treatment strategies for schizophrenia from improved understanding of genetic risk","volume":"86","author":"Morris","year":"2014","journal-title":"Clin. Genet."},{"issue":"11","key":"10.1016\/j.schres.2016.12.017_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003625","article-title":"Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum","volume":"3","author":"Mudge","year":"2008","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.schres.2016.12.017_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000373","article-title":"A genome-wide investigation of SNPs and CNVs in schizophrenia","volume":"5","author":"Need","year":"2009","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.schres.2016.12.017_bb0140","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/schbul\/sbu048","article-title":"Oxidative\/Nitrosative stress in psychiatric disorders: are we there yet?","volume":"40","author":"O'Donnell","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2016.12.017_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Perala","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2016.12.017_bb0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/01677063.2014.882918","article-title":"Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia","volume":"28","author":"Pietersen","year":"2014","journal-title":"J. Neurogenet."},{"issue":"1\u20132","key":"10.1016\/j.schres.2016.12.017_bb0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/01677063.2013.878339","article-title":"Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia","volume":"28","author":"Pietersen","year":"2014","journal-title":"J. Neurogenet."},{"issue":"5","key":"10.1016\/j.schres.2016.12.017_bb0160","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/schbul\/sbw059","article-title":"Genome-wide association studies suggest limited immune Gene enrichment in schizophrenia compared to 5 autoimmune diseases","volume":"42","author":"Pouget","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"11","key":"10.1016\/j.schres.2016.12.017_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000235","article-title":"An aPKC-Exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation","volume":"7","author":"Rosse","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.schres.2016.12.017_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baw100","article-title":"The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins","volume":"2016","author":"Rouillard","year":"2016","journal-title":"Database (Oxford)"},{"issue":"5","key":"10.1016\/j.schres.2016.12.017_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.schres.2016.12.017_bb0180","article-title":"The role of cell adhesion molecules in brain wiring and neuropsychiatric disorders","author":"Sakurai","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"issue":"7510","key":"10.1016\/j.schres.2016.12.017_bb0185","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.schres.2016.12.017_bb0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/15622975.2010.530690","article-title":"Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study","volume":"12","author":"Schmitt","year":"2011","journal-title":"World J. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2016.12.017_bb0195","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/mp.2011.123","article-title":"Hypothesis review: are clathrin-mediated endocytosis and clathrin-dependent membrane and protein trafficking core pathophysiological processes in schizophrenia and bipolar disorder?","volume":"17","author":"Schubert","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2016.12.017_bb0200","doi-asserted-by":"crossref","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2016.12.017_bb0205","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"issue":"1","key":"10.1016\/j.schres.2016.12.017_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2014.06.021","article-title":"Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a \u201ccentral hub\u201d in schizophrenia pathophysiology?","volume":"176","author":"Steullet","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.12.017_bb0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2012.11.001","article-title":"Roles of glial cells in schizophrenia: possible targets for therapeutic approaches","volume":"53","author":"Takahashi","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.schres.2016.12.017_bb0220","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/507566","article-title":"Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene","volume":"79","author":"Tosic","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.schres.2016.12.017_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036351","article-title":"Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416305916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416305916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:45:59Z","timestamp":1749854759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416305916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":45,"alternative-id":["S0920996416305916"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.12.017","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of differential gene expression mediated by clozapine in human postmortem brains","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}